Falade-Nwulia O, Thio C
Sex Health. 2011; 8(4):512-20.
PMID: 22127037
PMC: 5474943.
DOI: 10.1071/SH10163.
Jang J, Chung R
Gut Liver. 2011; 5(2):117-32.
PMID: 21814590
PMC: 3140655.
DOI: 10.5009/gnl.2011.5.2.117.
Gadalla S, Preiss L, Eyster M, Goedert J
J Viral Hepat. 2010; 18(3):161-9.
PMID: 20337924
PMC: 2929328.
DOI: 10.1111/j.1365-2893.2010.01289.x.
High K
Int J Hematol. 2002; 76(4):310-8.
PMID: 12463593
DOI: 10.1007/BF02982689.
Santana Rodriguez O, Male Gil M, HernandezSantana J, Canal J, Martin Sanchez A
Eur J Epidemiol. 1998; 14(6):555-61.
PMID: 9794122
DOI: 10.1023/a:1007410707801.
Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs.
Ghany M, Leissinger C, Lagier R, Lok A
Dig Dis Sci. 1996; 41(6):1265-72.
PMID: 8654162
DOI: 10.1007/BF02088247.
Hepatitis B and C infection in an institution for the mentally handicapped.
Torre D, Giola M, Zeroli C, Ferrario G, Broggini M, AGRIFOGLIO L
Infection. 1993; 21(6):410-1.
PMID: 8132375
DOI: 10.1007/BF01728927.
Prevalence of antibodies to hepatitis C virus among Omani patients with renal disease.
Al-Dhahry S, Aghanashinikar P, Al-Hasani M, Buhl M, Daar A
Infection. 1993; 21(3):164-7.
PMID: 7690010
DOI: 10.1007/BF01710538.
Lower prevalence of anti-hepatitis C antibody in dialysis and renal transplant patients in Ireland.
Conlon P, Walshe J, Smyth E, McNamara E, Donohoe J, Carmody M
Ir J Med Sci. 1993; 162(4):145-7.
PMID: 7685747
DOI: 10.1007/BF02942105.
Virological features of hepatitis C virus infection in hemodialysis patients.
Silini E, Bono F, Cerino A, Piazza V, Solcia E, Mondelli M
J Clin Microbiol. 1993; 31(11):2913-7.
PMID: 7505292
PMC: 266154.
DOI: 10.1128/jcm.31.11.2913-2917.1993.
Evidence for persistent hepatitis C virus (HCV) infection in hemophiliacs.
Allain J, Dailey S, Laurian Y, Vallari D, Rafowicz A, Desai S
J Clin Invest. 1991; 88(5):1672-9.
PMID: 1939652
PMC: 295699.
DOI: 10.1172/JCI115482.
Hepatitis C in deceased drug addicts.
Trubner K, Polywka S, Puschel K, Laufs R
Int J Legal Med. 1991; 104(5):251-4.
PMID: 1782144
DOI: 10.1007/BF01369579.
Incidence, prevalence, and clinical course of hepatitis C following liver transplantation.
Shah G, Demetris A, Gavaler J, Lewis J, Todo S, Starzl T
Gastroenterology. 1992; 103(1):323-9.
PMID: 1612340
PMC: 2978968.
DOI: 10.1016/0016-5085(92)91130-v.
HCV and HBV infection among multitransfused thalassemics from eastern Sicily.
Cacopardo B, Russo R, Fatuzzo F, Cosentino S, Lombardo T, La Rosa R
Infection. 1992; 20(2):83-5.
PMID: 1374737
DOI: 10.1007/BF01711069.
Immunoglobulin preparations from hepatitis C antibody-positive plasma donors: influence on diagnosis and risk of infection in heart transplant recipients.
Prohaska W, Wolff C, Schluter K, Koster-Eiserfunke W, Korner M, Kleesiek K
Clin Investig. 1992; 70(7):573-8.
PMID: 1327328
DOI: 10.1007/BF00184795.
Prevalence of hepatitis C virus antibody in a liver transplantation population.
Hassanein T, Gavaler J, Van Thiel D
Dig Dis Sci. 1992; 37(7):1110-5.
PMID: 1319888
DOI: 10.1007/BF01300295.
